Systematic Investigation of Halogen Bonding in Protein-Ligand Interactions.

APRSVDWREKGYVTPVKNQGQCGSCWAFSATGALEGQMFRKTGRLISLSEQNLVDCSGPQGNEGCNGGLMDYAFQYVQDN
GGLDSEESYPYEATEESCKYNPKYSVANDTGFVDIPKQEKALMKAVATVGPISVAIDAGHESFLFYKEGIYFEPDCSSED
MDHGVLVVGYGFESTESDNNKYWLVKNSWGEEWGMGGYVKMAKDRRNHCGIASAASYPTV

DESIGN OF NON-COVALENT INHIBITORS OF HUMAN CATHEPSIN L.FROM THE 96-RESIDUE PROREGION TO OPTIMIZED TRIPEPTIDES

CRYSTAL STRUCTURE OF A CYSTEINE PROTEASE PROFORM

CRYSTAL STRUCTURE OF MHC CLASS II ASSOCIATED P41 II FRAGMENT IN COMPLEX WITH CATHEPSIN L

ORIGINAL COMPOUND (2S,4R)-4-(2-CHLORO-BENZENESULFONYL)-1- (1-P-TOLYL-CYCLOPROPANECARBONYL)-PYRROLIDINE-2-CARBOXYLIC ACID (1-CYANO-CYCLOPROPYL)-AMIDE REACTS WITH CYS TO FORM THE COMPOUND PRESENT VIA REDUCTION OF THE TRIPLE BOND